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CRISPR-Cas is an adaptive prokaryotic immune system that prevents phage
infection. By incorporating phage-derived ‘spacer’ sequences into CRISPR
loci on the host genome, future infections from the same phage genotype
can be recognized and the phage genome cleaved. However, the phage
can escape CRISPR degradation by mutating the sequence targeted by the
spacer, allowing them to re-infect previously CRISPR-immune hosts, and
theoretically leading to coevolution. Previous studies have shown that
phage can persist over long periods in populations of Streptococcus thermo-
philus that can acquire CRISPR-Cas immunity, but it has remained less
clear whether this coexistence was owing to coevolution, and if so, what
type of coevolutionary dynamics were involved. In this study, we performed
highly replicated serial transfer experiments over 30 days with S. thermophi-
lus and a lytic phage. Using a combination of phenotypic and genotypic
data, we show that CRISPR-mediated resistance and phage infectivity co-
evolved over time following an arms race dynamic, and that asymmetry
between phage infectivity and host resistance within this system eventually
causes phage extinction. This work provides further insight into the way
CRISPR-Cas systems shape the population and coevolutionary dynamics
of bacteria–phage interactions.
This article is part of a discussion meeting issue ‘The ecology and
evolution of prokaryotic CRISPR-Cas adaptive immune systems’.1. Introduction
Clustered regularly interspaced short palindromic repeats and their
associated cas genes (CRISPR-Cas) form an adaptive immune system that
is found in approximately 50% of all bacteria and 90% of archaea [1].
CRISPR-Cas confers immunity to phage infection by incorporating
phage-derived sequences into CRISPR loci on the host genome. These
loci consist of repeating sequences (repeats) that are interspaced by
sequences (spacers) derived from phage and other mobile genetic elements
of typically around 30 nt in length. RNA transcripts of CRISPR loci are pro-
cessed and form a ribonucleoprotein complex with Cas proteins that can
recognize and cleave complementary nucleic acid sequences, preventing
future infections by the same phage genotype. CRISPR-Cas systems are
highly diverse and are currently ordered into two classes, six types and
33 subtypes based on their cas gene composition, gene synteny
and CRISPR repeat sequences, with clear differences in the molecular
mechanisms of different variants [2].
In some natural environments, bacteria with CRISPR-Cas systems appear to
coevolve with phage over long time periods [3,4]. However, studying the
dynamics of these coevolutionary interactions under controlled laboratory con-
ditions has been limited by the availability of adequate model systems.
Specifically, while many bacteria encode CRISPR-Cas immune systems,
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2under laboratory conditions, the vast majority do not evolve
CRISPR-based immunity upon phage or plasmid infection or
do so at such low frequencies that they are detectable only
with deep-sequencing approaches. Such low-frequency
CRISPR evolution is unlikely to significantly contribute to
the reciprocal selection between the bacteria and the phage.
Currently, only two bacterial species have been found to
naturally evolve (almost) exclusively CRISPR-based immu-
nity under laboratory conditions: Streptococcus thermophilus
strains DGCC7710 and LMD-9 [5–7], and Pseudomonas
aeruginosa strain UCBPP-PA14 [8].
Early studies with S. thermophilus demonstrated that
phage can overcome CRISPR immunity by evolving point
mutations in the sequence targeted by the spacer (the ‘pro-
tospacer’), or in the protospacer-adjacent motif (PAM) [5],
a conserved sequence immediately adjacent to the proto-
spacer that is used by the bacteria to discriminate
between self (i.e. CRISPR loci) and non-self (i.e. phage)
DNA [9–11]. This observation suggested a possible scen-
ario for coevolution in free-running systems, where
bacteria acquire spacers over time and phage escape via
point mutations in the corresponding protospacers or
PAMs [12–14]. Consistent with this idea, it was reported
that S. thermophilus can coexist with phage over many gen-
erations and that for each treatment the single
experimental population displayed large fluctuations in
its spacer repertoire and an increase in the frequency of
point mutations in phage genomes over time [15–17].
However, a more recent study suggested that coevolution
is unable to explain long-term coexistence of
S. thermophilus and its phage, suggesting instead that this
may be driven by a back mutation of bacteria with
CRISPR immunity to sensitive phenotypes [18], which
would provide a continuous supply of sensitive hosts for
the phage to amplify in. Such loss of CRISPR immunity
owing to mutation has also been observed at high frequen-
cies in Staphylococcus epidermidis [19], and reversion to
sensitive phenotypes more generally may be an important
mechanism for bacteria–phage coexistence [20].
Given the lack of clarity surrounding the role, if
any, and the type of CRISPR–phage coevolution for bac-
teria–phage coexistence, we performed highly replicated,
long-term (30-day) serial transfer experiments with
S. thermophilus and its lytic phage 2972. Our phenotypic
assays demonstrate that bacteria and phage coevolved in
these experiments during at least the first 9 days (approxi-
mately 70 generations). We next examined the type of
coevolutionary dynamics during this period, with a
clear distinction between fluctuating selection dynamics
(FSD), where the rare host and pathogen genotypes are
favoured through negative frequency-dependent selec-
tion, and arms race dynamics (ARD), where host
resistance and phage infectivity increase over time [21].
We found that CRISPR-mediated immunity and phage
infectivity increase over time. Further, our genotypic data
show that patterns of resistance and infectivity were
explained by bacteria acquiring novel spacers against
the phage, and the phage evolving mutations in the
regions targeted by the spacers. Collectively, the data
show that coevolution is probably an important factor in
the coexistence of bacteria and phage in this empirical
system and that this coevolution is characterized by
an ARD.2. Experimental methods
(a) Strains used in the study
We used the lactic acid bacterium S. thermophilus DGCC7710
wild-type (WT) and its lytic pac-type phage 2972 (GenBank:
NC_007019.1) [22] as a model system. DGCC7710 has four
CRISPR-Cas systems, two of which (CRISPR1 and CRISPR3) are
active during infection with phage 2972 and both are classified
as type II-A [7,23]. CRISPR1 has 32 spacers and CRISPR3 has
12 spacers [7,24], none of which are perfectly complementary to
a PAM-flanked sequence in the phage 2972 genome.
(b) Phage 2972 amplification
An overnight culture of S. thermophilus was transferred 1 : 10
into fresh LM17 medium (M17 broth supplemented with 0.5%
a-lactose) containing 10 mM CaCl2 and incubated shaking at
180 revolutions per minute (rpm) at 428C. When the culture
reached log phase (OD600  0.25) approximately 106 plaque-
forming units (PFU) of phage 2972 were added and the culture
was incubated under the same conditions for 2 h, at which
point cells had fully lysed. Lysates were centrifuged and filtered
through a 0.22 mm filter, and the resulting phage stocks were
stored at 48C.
(c) Long-term co-culture experiment
Prior to commencing the experiment, S. thermophilus was
acclimatized in LM17 medium at 428C and 180 rpm for 2 days,
with a 1 : 100 transfer into fresh LM17 after 24 h (approx.
106 colony forming units (CFU)). To start the co-culture exper-
iment, overnight cultures of the bacteria were transferred 1 : 100
into 6 ml LM17 media supplemented with 10 mM CaCl2 in
glass vials. They were then infected with either 109, 108, 107 or
106 PFU of phage 2972, with 12 independent replicate exper-
iments per treatment, followed by incubation at 428C while
shaking at 180 rpm. Replicates were transferred 1 : 100 into
fresh LM17 þ 10 mM CaCl2 every 24 h and phage titres and
bacterial densities were measured every 24 h for a period of
30 days, or until no phage was detected for four consecutive
days. Bacterial densities were determined through plating and
colony counts, while phage densities were measured by plaque
assays. These were performed by mixing phage dilutions with
WT bacteria in soft agar overlays (LM17 þ 10 mM CaCl2 and
0.5% agar), poured onto hard agar (LM17 þ 10 mM CaCl2
and 1.5% agar).
(d) Phage survival
Phage survival and mean time to extinction over the course of
the experiment were analysed using a Cox proportional hazards
model from the survival package [25].
(e) Measuring the evolution of infectivity and resistance
To measure whether host resistance and phage infectivity
evolved during their co-culture, we isolated phage clones and
bacterial clones from the treatment where bacteria were infected
with 108 PFU phage. To give sufficient power in this analysis, we
focused on eight replicate experiments from this treatment where
phage persisted for at least 9 days, a period which we estimated
to be sufficiently long for significant coevolution to take place.
Phage extracted from 1, 4 and 9 days post-infection (dpi) were
subjected to plaque assays as described above. Three time
points were chosen as a minimal requirement for the down-
stream time-shift analysis to monitor whether coevolution took
place and to determine the coevolutionary dynamics (see
below). For each replicate and time point, 12 plaques were ran-
domly picked and amplified in 96-well plates containing
Table 1. Pairwise challenges between phage and hosts in the time-shift
assay. (Numbers indicate the time points (days post-infection) analysed.
Past, present or future refer to if hosts were contemporaneous or not with
respect to the phage.)
phage
host 1 4 9
1 present future future
4 past present future
9 past past present
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3LM17 þ 10 mM CaCl2 in which WT bacteria were inoculated 1 :
100 from a fresh overnight culture. Bacteria extracted from the
same time points were diluted and plated overnight, and 12 colo-
nies from each replicate were picked at random and used to make
soft agar overlays on LM17 agar lawns. To examine the evolution
of phage infectivity for each of the eight replicates, the 36 phage
clones that were isolated (12 phage clones  3 time points) were
stamped using a 96-pin replicator onto 36 bacterial lawns corre-
sponding to the bacterial clones isolated from the same replicate
(i.e. 12 bacterial clones  3 time points). Phage were classified as
being infective against a particular bacterial clone if a clear lysis
zone was visible on the lawn after incubation at 428C for 24 h.
If no lysis zone was visible, the host was classified as resistant.
( f ) Evolution of infectivity and resistance
Using the data from the experiments described above, we
measured the evolution of phage infectivity as the proportion
of bacterial clones that phage from each time point from
the same replicate experiment could infect (i.e. how phage
infectivity range changed over time). In a similar way, we
measured the evolution of host resistance as the proportion of
all phage genotypes from the same replicate experiment that
could be resisted by bacteria from each time point (i.e. how
host resistance range changed over time). Infectivity or resistance
was analysed in a generalized linear model (GLM) with geno-
type as a fixed effect and a binomial family with a logit link
function. Mean infectivity or resistance was then analysed for
each time point in a generalized linear mixed model (GLMM)
using the lme4 package [26], with time point as a fixed effect
and replicate as a random effect. Model coefficients and confi-
dence intervals were transformed from logits to probabilities
prior to presentation.
(g) Time-shift experiment
Because the susceptibility and resistance of bacterial clones to
phage from past, present or future time points was determined
(table 1), our phenotypic assay also served as a time-shift exper-
iment [27]. Time-shift experiments involve challenging samples
of host or pathogen populations from a particular time point
against samples of pathogen or host populations from contempor-
ary, past and future host or pathogen populations. Time-shift
experiments are a powerful tool to characterize underlying coevo-
lutionary processes and have been used in several host–pathogen
systems [28,29], including bacteria–phage [30–32]. Our phage
infectivity and host resistance data were analysed as a time-shift
experiment by first scoring each pairwise challenge as ‘past’, ‘pre-
sent’ or ‘future’, with reference to the phage’s background
compared to the host. Infectivity was then analysed in a GLMM
with phage background as a fixed effect and replicate, host time
point and phage time point as random effects. Models had a
binomial family with a logit link function.
To test for the relative importance of ARD versus FSD,
we estimated the strength of the genotype  environment (G 
E) effect on infectivity and resistance following Hall et al. [31].
Under ARD, all hosts should be more susceptible to phage
from their future compared to their past or present, independent
of genotype. Environment (E) therefore refers to the time point
from which phage originate in pairwise challenges. By contrast,
under FSD, different host genotypes will vary in their suscepti-
bility to hosts from their past, present or future. Measuring
which proportion of the variation in susceptibility across
phage environments can be explained by the interaction
between the environment and host genotype (G) can therefore
be used to measure the relative contribution of FSD. Increasing
values of this proportion (G  E/E) relate to increasing differ-
ences in susceptibility among host genotypes. We estimated
this by calculating the ratio of the mean square (MS) of anenvironment-only model to the MS of a G  E model for each
replicate at each time point. These ratios were then analysed in
a GLMM with a time point as a fixed effect and replicate as
a random effect, with a normal family and square root
link function.3. Statistical methods
For all experiments, statistical analyses were carried out in R
v3.5.0 [33], and graphics were generated using r-base and
the ggplot2 package [34]. Model selection followed a
nested design, and the final models in all analyses were
selected based on the reduction of heteroskedacity, x2 tests
and Akaike information criterion comparisons [35–37].
Where appropriate, tests were Bonferroni adjusted using the
multicomp package [38].
(a) Spacer sequence analysis
For all bacterial clones that were isolated from the eight replicate
experiments where bacteria had been infected with 108 PFU of
2972, expansion of the CRISPR1 and CRISPR3 arrays was ana-
lysed using colony polymerase chain reaction (PCR) to
determine whether spacer acquisition had taken place (12
clones 3 time points 8 replicates¼ 288 clones in total). The
following primers were used: CRISPR1 50-TGCTGAGACAACC-
TAGTCTCTC-30 and 50-TAAACAGAGCCTCCCTATCC-30;
CRISPR3 50-CTGAGATTAATAGTGCGATTACG-30 and 50-
GCTGGATATTCGTATAACATGTC-30. Clones that had acquired
new spacers were further analysed by Sanger sequencing of
the amplicon (Source Bioscience, UK), followed by mapping
of the spacers against the phage 2972 genome using BLAST
followed by manual verification with GENEIOUS v9.1.8 [39].
Spacer diversity was calculated as the pairwise difference
(PWD) among nucleotides between spacer sequences. The
effect of spacer number and diversity on infectivity was
analysed in a GLMM, with either number or diversity as
fixed effects and replicate as a random effect. Models had a
binomial family and logit link function.
(b) Phage sequence analysis
To understand whether phages could escape CRISPR immu-
nity through target site (protospacer) mutation, we selected
phage clones (out of the 288 total phage clones isolated, see
above) and sequenced the protospacer(s) that would match
the spacer(s) present among the 12 isolated bacterial clones
in a replicate. We then analysed the protospacers and their
associated PAMs for single nucleotide polymorphisms
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4(SNPs) that could explain the ability of the phage to overcome
CRISPR immunity. For phage clone selection, we used the
individual infectivity matrices generated from our phenoty-
pic assays (electronic supplementary material, table S1), and
we only sequenced phage clones from infection matrices
that showed phage infectivity on hosts that had acquired
spacers, i.e. excluded from analysis were phages from those
matrices where none of the 12 host clones of a replicate had
acquired spacers or where none of the 12 phage clones of a
replicate showed infectivity. Sequenced phage clones were
taken from 1, 4 and 9 dpi. At least two individual phage
clones were selected from each matrix that was analysed,
based on their ability to infect CRISPR-immune hosts.
When an infection matrix showed a high degree of variation
between phage clones, more than two phage clones were ana-
lysed so that most of the variation in infectivity would be
covered (e.g. in the matrix of replicate 7, T9 phage:T9 host,
phage clones 1, 2, 5, 6, 8 and 9 were selected (electronic sup-
plementary material, table S1)). Where possible, one phage
clone that did not show infectivity to any of the 12 bacterial
clones from each matrix was taken along to serve as a control
for protospacer sequencing, alongside an ancestral phage as
control. Primers for protospacer sequencing were designed
in GENEIOUS by using the available spacer information (elec-
tronic supplementary material, tables S2 and S3). PCR
amplicons of a total of 51 phage clones were generated by
performing PCR on the filtered phage stock, which was fol-
lowed by Sanger sequencing. To identify point mutations,
sequences were first mapped to the 2972 genome using GEN-
EIOUS. SNPs in either the seed sequence or PAM were
identified [5,7], and SNP locations were then compared
against the protospacer sequence targeted by the CRISPR
array of each clone that phage had been challenged against
(electronic supplementary material, table S4). Phage with
SNP(s) in the seed sequence or PAM of the targeted protospa-
cers were scored as ‘predicted infective’. We found that
approximately 70% (241 out of 348) of predicted infectious
phage were measured as successfully infecting a host
(table 3). The remaining predicted infections that were not
measured as successful may be attributable to partial
CRISPR resistance or other resistance mechanisms such as sur-
facemodification.We also expect some degree of experimental
error in our assay given that the detection of lysis zones is a
relatively crude method of discerning infectivity/resistance.
Using data from the phenotypic assay, we then analysed the
effect of the mutation on infectivity. The effect of escape by
point mutation on infectivity was modelled in a GLMM as
the proportion of infections associated with phage that had
an SNP in the protospacer seed sequence or PAM.We analysed
the effect of the evolution of the number of SNPs in all
targeted sequences matching the host’s CRISPR array by first
subtracting the number of targeted protospacers that had
evolved from the total number of spacers in each host. This
gives the number of targeted sequences that had not evolved.
The proportion of infections was then modelled against these
values. All models included replicate as a random effect, and
used a binomial family with a logit link function.4. Results
We set out to first examine the generality of the previously
reported population dynamics following infection of S.thermophilus DGCC7710 with a single phage 2972. We therefore
infected 12 replicate experimental populations of S. thermophilus
DGCC7710 with either 106, 107, 108 or 109 PFU of phage 2972 (12
independent replicates per treatment; 48 populations in total)
and monitored the bacterial and phage population densities
on a daily basis for 30 days. For the first 3 days following infec-
tion, phage titres remained fairly constant in most replicates
between 106 and 108 PFUml21, with the exception of the highest
phage treatment (109 PFU) where phage and bacteria went
extinct in 11 out of 12 replicates (figure 1). Lower phage titres
were correlated with higher host densities (z¼ 20.31, 95% con-
fidence interval (CI)¼ 20.42, 20.19, p, 0.0001). With the
exception of the 109 treatment, this relationship between phage
and host titres was the same among treatments (F2,551¼ 2.24,
p¼ 0.11). At 16 days post-infection (dpi), the phage had gone
extinct in 44 out of 48 replicates, and phage persisted for the
entire 30 day duration of the experiment in two replicates, one
each in the 107 and 108 PFU treatments. For the treatments
where bacteria survived, the mean time until phage extinction
in days was as follows: for the 109 PFU treatment: 2+0.54
days; 108 treatment: 11.50+1.77 days; 107 treatment: 11.50+
2.12 days; and 106 treatment: 7.67+1.67 days (mean+
standard error).
Using these experimental lines, we first determined
whether the coexisting bacteria and phage had evolved
during their co-culture. Since the population dynamics
associated with the 106–108 PFU infection regimes was vir-
tually identical, we decided to limit our downstream
analyses to the 108 treatment only. Further, to achieve suffi-
cient power in our analyses and deduce coevolutionary
dynamics, we selected replicates where bacteria and phage
coexisted for at least 9 days, resulting in a total of eight repli-
cate populations that were examined in detail (figure 1). We
then isolated 12 bacterial clones and 12 phage clones from
each replicate at 1, 4 and 9 days post-infection (dpi). Using
the 288 phage and 288 bacterial isolates, we first examined
whether the phage and bacteria had evolved increased infec-
tivity and resistance over time. This was done by measuring
the resistance of each individual bacterial clone against all
phage clones derived from the same replicate and measuring
the infectivity of each individual phage clone against all bac-
terial clones from the same replicate. This analysis revealed
that mean phage infectivity (the proportion of all host geno-
types that can be infected by a given phage genotype)
increased significantly from 0.29 (CI ¼ 0.08, 0.48) at 1 dpi to
0.57 (CI ¼ 0.37, 0.74) at 4 dpi, but remained stable at 0.53
(CI ¼ 0.33, 0.74) from 4 to 9 dpi. Mean host resistance (the
proportion of all phage genotypes resisted by a given host
genotype) increased significantly each time point, from 0.01
(CI ¼ 0.00, 0.05) at 1 dpi to 0.67 (CI ¼ 0.18, 0.96) at 4 dpi,
and to 0.99 (CI ¼ 0.96, 0.99) at 9 dpi (figure 2). Collectively,
these data show that bacteria evolved to resist essentially all
phage genotypes by 9 dpi, but phage did not evolve high
levels of infectivity to match.
Having established that bacteria evolved increasing resist-
ance and that phage evolved increasing infectivity over time,
we next examined whether both species coevolved; and if so,
what type of coevolutionary dynamics were associated
with this system. To answer this question, we performed a
phenotypic time-shift experiment whereby bacteria were
exposed to phage from their past, present and future [27,32]
which enabled us to measure infectivity and resistance pat-
terns over time. GLMMs with replicate, host time point and
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Figure 1. Phage and host population dynamics over time in each replicate. (a–d ) 109–106 PFU phage treatments, respectively, with replicate identity indicated
above each sub-panel. Phage titres ( plaque-forming units; PFU ml21) are shown in black and host densities (colony-forming units; CFU ml21) are shown in blue.
The level of detection is 200 PFU ml21 (dashed line).
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Figure 2. Evolution of infectivity and resistance over time. (a) Phage infectivity over time, represented as the proportion of host genotypes from all time points that
were infected by a given phage genotype in each replicate. (b) Host resistance over time, represented as the proportion of phage genotypes from all time points that
were resisted by a host genotype in each replicate. Means and 95% CIs are shown (n ¼ 8).
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5phage time point as random effects and phage background
(table 1) as a fixed effect were used to analyse time-shift
data. This analysis showed that the original time point of
the phage with respect to the host had a significant effect
on infectivity (x24,10044 ¼ 5:35, p, 0.0001, R2 ¼ 0.88). Hosts
were least susceptible to infection from past phage, more sus-
ceptible to contemporaneous phage, and most susceptible tophage from their future (figure 3a). This pattern of increasing
susceptibility from past to future phage generally held true
when each pairwise combination of host and phage time
point was considered (electronic supplementary material,
figure S1 and table 2). Finally, host susceptibility to phage
from the same time point declined consistently from 1 to
9 dpi (figure 3b). These data are consistent with an ARD
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Figure 3. Results from time-shift experiment. (a) Proportion of hosts infected when phage were from the host’s past, present or future. (b) Proportion of hosts
infected by phage from the same time point (days post-infection). The dotted line is for illustrative purposes. Means are shown. 95% CIs represent the variation of
the mean among replicates (n ¼ 100 048).
Table 2. Mean proportion and 95% conﬁdence interval (CI) of hosts
infected and phage resisted in pairwise challenges in the time-shift
experiment, broken down by the day from which the host or phage
originated. (Values are rounded to two decimal places.)
host phage
mean
infectivity
infectivity
95% CI
t1 t1 0.98 0.80–1.00
t4 t1 0.17 0.01–0.20
t9 t1 0 0.00–0.00
t1 t4 0.90 0.80–1.00
t4 t4 0.74 0.67–0.97
t9 t4 0.01 0.00–0.19
t1 t9 0.85 0.80–0.99
t4 t9 0.79 0.78–0.98
t9 t9 0.36 0.07–0.56
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6where hosts and pathogens escalate resistance or infectivity
over time, but one in which host resistance eventually
outpaces pathogen infectivity.
We formally tested for the relative importance of ARD
versus FSD in our experiment by estimating the strength of
the genotype  environment (G  E) effect on infectivity and
resistance [31]. Stronger G  E effects are consistent with stron-
ger FSD (see Experimental methods). This analysis showed
that variation among genotypes was weak, consistent with a
limited G  E effect (electronic supplementary material,
figure S2A,B). The strength of the G  E effect did not
change significantly with respect to time point for either
phage infectivity (x22,24 ¼ 1:93, p ¼ 0.38, R2 ¼ 0.13) or host
resistance (x22,24 ¼ 1:46, p¼ 0.48, R2 ¼ 0.11). Collectively,
these data demonstrate that S. thermophilus DGCC7710 and
phage 2972 coevolved under these experimental conditions
and that the dynamics of their coevolution predominantly
follows an arms race.
Based on previous studies showing that S. thermophilus
typically acquires spacers in response to phage exposure
[5,15,16], we predicted that this ARD was driven by recipro-
cal adaptation of the hosts’ CRISPR array and the phage
protospacers it targets. To test this, we first performed PCR
analysis on the CRISPR1 and CRISPR3 loci of each bacterial
clone to verify that the mechanistic basis of resistance was
in fact because of the acquisition of novel CRISPR spacers.
This revealed that the mean number of spacers per clone
increased over time (x26,1140 ¼ 32:9, p, 0.0001) (figure 4a),
and that all clones sequenced at 9 dpi had acquired at least
one spacer (M ¼ 0.55, CI ¼ 0.45, 0.65) (figure 4b). Compari-
son of these spacer sequences with the 2972 genome
confirmed that they were acquired from the phage.
Using these sequencing data, we determined the level of
spacer diversity that naturally evolved within each replicate,
because this is an important determinant of CRISPR–phage
coevolution [40,41]. Consistent with deep-sequencing ana-
lyses of previous co-culture experiments [15,16], our data
showed that spacer diversity, measured as the PWD (with 0
indicating all spacers were shared among clones, and 1 indi-
cating all spacers were unique) among spacer sequences, was
generally low (grand mean ¼ 0.25). Despite this, there was
clear qualitative variation in spacer diversity between differ-
ent replicates (figure 4c). Mean CRISPR genotype richness—
the number of different CRISPR alleles we detected—wasalso low, but increasing, across the sampled time points
(1 dpi ¼ 1, 4 dpi ¼ 1.5, 9 dpi ¼ 2.25). The diversity patterns
become especially apparent when the spacers are mapped
against the phage genome (figure 5) which shows that the
spacer composition between time points can change completely,
suggestive of selective sweeps of the population.
Consistent with previous theory and data [40,41], we
found that host resistance increased with both the number
of acquired spacers (C ¼ 1.91, z ¼ 17.22, p, 0.0001, R2 ¼
0.66) (electronic supplementary material, figure S3A) and
sequence diversity in terms of PWD (C ¼ 5.26, z ¼ 0.27, p,
0.0001, R2 ¼ 0.44) (electronic supplementary material, figure
S3B). These data demonstrate that all clones that had acquired
resistance had also acquired at least one novel spacer in either
CRISPR1 or CRISPR3, suggesting that resistance is CRISPR-
mediated. Further, Sanger sequencing of all CRISPR
amplicons confirmed that all spacers which had been
acquired indeed targeted the phage 2972 genome (electronic
supplementary material, table S2). Spacers most frequently
mapped to phage genes encoding hypothetical proteins com-
pared to proteins with known functions, and the targeted
genes tended to be at the distal end of the phage genome
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7(electronic supplementary material, table S2). We next tested
the hypothesis that the coevolutionary arms race we observed
in these experiments was caused by reciprocal adaptation of
the phage through the acquisition of point mutations in the
target sequences. Such mutations have been observed in a
previous co-culture experiment [16] and provide a known
mechanism for the phage to overcome CRISPR resistance[5]. To examine whether phage infectivity could be explained
by the acquisition of point mutations, we first selected from
the phenotypic assays a representative number of 56 different
phage clones with different infectivity patterns (i.e. covering
both infective and non-infective phenotypes) across the
three time points included in the phenotypic assay. We
then PCR amplified their protospacer sequences based on
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Table 3. Contingency table of pairwise infections that were predicted to
lead to phage escape based on protospacer sequence data. (Single
nucleotide polymorphisms (SNPs) in either the seed sequence or PAM were
identiﬁed, and SNP locations were then compared against the protospacer
sequence targeted by the CRISPR array of each clone that phage had been
challenged against. These were then compared against the pairwise
infections measured in the phenotypic assay. ‘þ ’ indicates a successful
infection, ‘2 ’ indicates no infection.)
predicted
2 1
measured – 242 107
þ 106 241
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8the CRISPR spacer sequence data, followed by Sanger
sequencing of the amplicons. This showed that 38 out of 51
selected phage clones had acquired at least one SNP in the
protospacer sequence or PAM (figure 6a); the majority [32]
of which were protospacer mutations (figure 6b). Further,
the majority (approximately 70%) of phage that were pre-
dicted to be infectious based on sequence data were able to
successfully infect hosts (table 3), indicating that SNPs in
the protospacer or PAM were generally sufficient to confer
infectivity. The proportion of sequenced phage clones with-
out SNPs in the protospacer or PAM from 4 dpi (10 out of
22) was higher than phage clones from 9 dpi (4 out of 26)
(electronic supplementary material, table S3), which is con-
sistent with the idea that CRISPR drives mutation of phage
genomes in this empirical system [16]. Crucially, analysis of
the infectivity patterns of sequenced phage showed that the
mean number of infected hosts was significantly higher
when phage had an SNP in the protospacer sequence or
PAM compared to phage with no detectable mutations
(x21,696 ¼ 32:22, p, 0.0001, R2 ¼ 0.31) (figure 6c). Finally,
phage that had evolvedSNPs in all sequences thatwere targeted
by the host’s CRISPR array (0 targeted sequences) had signifi-
cantly higher infectivity compared to phage that carried one
or more unmutated target sequences (x21,696 ¼ 59:29 p,
0.0001, R2 ¼ 0.74) (figure 6d). These data demonstrate that the
acquisition of point mutations in the protospacer sequence inresponse to the evolution of CRISPR immunity is the primary
mechanism of phage reciprocal adaptation, driving the increase
in phage infectivity during the observed ARD.5. Discussion
Streptococcus thermophilus DGCC7710 readily evolves
CRISPR-based resistance in response to phage 2972 through
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9spacer acquisition in two active CRISPR loci (CRISPR1 and
CRISPR3). In return, phage can escape CRISPR immunity
by evolving point mutations in the protospacer sequences tar-
geted by CRISPR. This mechanism of host resistance and
pathogen infectivity suggests a possible scenario for coevolu-
tion, where bacteria acquire spacers over time and phage
accumulate escape mutations.
Consistent with earlier work on S. thermophilus and phage
2972 [15–18], we found that, with the exception of the highest
initial phage concentration treatment, the phage can coexist
with bacteria over many generations despite the presence of
CRISPR-based host immunity. Furthermore, our phenotypic
data using bacteria and phages isolated during the first
9 dpi demonstrated that they coevolved following an ARD,
with hosts and phage evolving increased resistance and infec-
tivity over time, and hosts being more resistant to phage from
the past compared to present and future time points. To the
best of our knowledge, the evolution of phage resistance is
exclusively driven by CRISPR-Cas in this empirical system
(i.e. surface modification has not been reported in S. thermo-
philus DGCC7710 in response to phage infections, and we
have also never observed it in our experiments). Consistent
with this, we found that the underlying mechanism of coex-
istence during this time span appears to be predominantly
reciprocal adaptation of the hosts’ CRISPR array and the
phage protospacers it targets. Analysis of hosts’ CRISPR
arrays shows that they readily acquire phage-derived spacers,
that hosts acquire more spacers over time, and that host
resistance is strongly associated with both spacer acquisition
and spacer number. In turn, phage evolved via point
mutations in the targeted protospacers. Correlating this
with our phenotypic data shows that such escape phage
were on average more infective. Further, we find that phage
had evolved SNPs in all target sequences matching the
host’s CRISPR array were most infective compared to those
with an incomplete match.
It is notable that while hosts evolve resistance against
essentially all phage, this is not matched by similarly broad
phage infectivity range; phage at the last time point (9 dpi)
could infect just over half of all hosts. The infectivity of con-
temporary phage also declines with time, suggesting that the
evolution of host resistance ‘outpaces’ that of phage infectiv-
ity. This asymmetry between host resistance and phage
infectivity is consistent with the idea that bacterial hosts are
‘ahead’ in coevolutionary arms races [42]. While asymmetri-
cal arms races in other studied bacteria–phage systems are
generally driven by a binary shift to a phage-resistant surface
mutant [8,43], CRISPR–phage interactions suggest an
alternative. Hosts can acquire multiple novel spacers with
only a marginal cost [44], but phage mutation is limited by
mutation supply [43,45,46] (also see Chabas et al. in this
issue). In addition, full phage infectivity requires mutations
in all the protospacers targeted by the host CRISPR array,
which becomes increasingly difficult when individual hosts
and populations acquire a greater number and diversity of
spacer sequences over time [41,45]. It is likely that this asym-
metry leads to the repeatable phage extinctions we observed.
Interestingly, this and previous studies occasionally
found quasi-stable long-term coexistence of bacteria and
phage [15–18]. Previous work suggests that this may be
driven by back mutation of resistant hosts towards sensitivity
[18]. These two mechanisms for bacteria–phage coexistence
may operate in parallel, and their relative importance remainsto be investigated. The relative importance of coevolution
for phage persistence contrasts with what is observed for
P. aeruginosa and its phage DMS3vir, where phage are
unable to coevolve with the host owing to the high levels
of spacer diversity that naturally evolve [41]. In this
system, a continuous supply of sensitive hosts can allow
for bacteria–phage coexistence [41,46,47].
Our data clearly shows that host genotype diversity rich-
ness (i.e. the number of hosts with different CRISPR arrays)
increases over time. These data, together with the rapid and
repeatable phage extinction after day 9 in our experiment,
indirectly support the idea that S. thermophilus hosts receive
a synergistic benefit from population-level CRISPR diversity
in the context of phage infection. Host diversity is a key deter-
minant of pathogen spread (reviewed in [48,49]), and
previous work on P. aeruginosa PA14 and S. thermophilus
has shown that population-level CRISPR spacer diversity
can limit phage persistence [41]. An understanding that
population diversity may provide such a benefit clarifies
other results from our data. Although phage infectivity was
still possible even with a partial match to the host’s
CRISPR array, in the context of a mixed, polyclonal host
population, such reduced infectivity may limit phage repro-
duction and transmission, sufficient to cause the rapid
extinctions we observed.
In at least some natural environments, bacteria that evolve
CRISPR resistance and the phage they target can coexist [3].
This may be owing to CRISPR–phage coevolution, as recently
observed for a fish pathogen and its phage [4], but long-term
coexistence may also be explained by various other ecological
and evolutionary factors that are absent from our simple
laboratory environments [50]. For example, previous exper-
iments suggest that longer periods of bacteria–phage
coexistence are reached when experimental treatments
contained multiple different phages [15,16]. Further, phage
under these conditions were found to escape not only by
mutation but also by recombination [16]. This is consistent
with observations from other natural environments where
phage recombinants were correlated with CRISPR activity [3].
These examples highlight how biotic and abiotic complexities
maybekey in shaping theecological andevolutionarydynamics
of host–pathogen interactions, which we are only starting to
understand in the context of CRISPR–phage interactions.
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